Suárez RÁE, Santana TRM, Pantoja TCO, Pérez ÁCE, Vázquez MH

Language: Spanish
References: 28
Page: 81-87
PDF size: 180.11 Kb.

ABSTRACT

Background: Gestational trophoblastic disease (GTD) comprises different types of placental changes distinguished by histologic hydropic degeneration and swelling of corionic villus.
Objective: To report incidence of gestational trophoblastic disease in a general hospital.
Material and methods: A cross-sectional study in the period of January 2000 to June 2006 was made. Histopathologic report of specimen abortion with gestational trophoblastic disease was registered and we calculated the incidence of births, abortions and total pregnancies.
Results: In the study period, 142 cases of gestational trophoblastic disease were registered, and an incidence of 1:243 births and 1:31 abortions (1:274 pregnancies) was found. The average age of patients was 27.1 years (15 to 50), 67% of the cases were not clinically suspected.
Conclusions: Histopathologic study of specimen abortions allows calculating precisely incidence of gestational trophoblastic disease, but the findings of this study may be different because numerators and denominators used in the calculation are not the same.

REFERENCES

1. American College of Obstetricians and Gynecologists: Management of Gestational Trophoblastic Disease. Technical bulletin No. 178, March 1993.

2. Ahued JR, Fernández del Castillo C, Bailón Uriza R. Ginecología y obstetricia aplicada. 2ª ed. México: El Manual Moderno, 2002;pp:323-30.

3. Lara MF, Alvarado MA, Candelaria M, Arce S. Neoplasia gestacional trofoblástica. Experiencia del INCan. Gama 2005;6:147-51.

4. Acaia B, Parazzini F, La Vecchia C, Ricciardiello O, Fedele L, Battista Candiani G. Increased frequency of complete hydatidiform mole in women with repeated abortion. Gynecol Oncol 1988;31:310-14.

5. Berkowitz RS, Goldstein DP. Presentation and management of molar pregnancy. In: Hancock BW, Newlands ES, Berkowitz RS, editors. Gestational trophoblastic disease. London: Chapman Hal, 1997;pp:127-42.

6. Fisher RA, Khatoon R, Paradinas FJ, Roberts AP, Newlands ES. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod 2000;15:594-8.

7. Ujeno Y. Epidemiological studies of human fetal development in area with various doses of natural background radiation. Arch Environ Health 1985;40(3):181-4.

8. Jacobs PA, Hunt PA, Matsurra JS, Wilson CC. Complete and partial hydatiform mole in Hawai: Cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 1982;89:258-66.

9. Barri PN. Pérdidas embrionarias periimplantatorias. En: Carrera JM, Kurjak A, editores. Medicina del Embrión. Colección de Medicina Materno-Fetal. Cap. 16. Barcelona, España: Departamento de Obstetricia y Ginecología, Instituto Universitario Dexeus, 1997;p:143.

10. Bracken MB, Brinton LA, Hayashi K. Epidemiology of hydatiform mole and choriocarcinoma. Epidemiol Rev 1984;6:52-75.

11. Aziz MF, Kampono N, Moegni EM, Sjamsuddin S, Barnas B, Samil RS. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Adv Exp Med Biol 1984;176:165-75.

12. Matzui H, Litsuka Y, Yamazawa K, Tanaka N, Seki K, Sekiya S. Changes in the incidente of molar pregnancies. A populationbased study in Chiba prefecture and Japan between 1974 and 2000. Hum Reprod 2003;18:172-5.

13. Bugti QA, Baloch N, Baloch MA. Gestational trophoblastic disease in Quetta. Pak J Med Res 2005;44:92-95.

14. Palmer JR, Driscoll SG, Rosenberg L, Berkowitz RS et al. Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 1999;91:635-40.

15. Zarain GAJ, Gamboa I, González E, Ayala AR. Frecuencia y control terapéutico de la enfermedad trofoblástica gestacional. Ginecol Obstet Mex 1986;54:8-11.

16. Walss RJ, Delgado RA, Rivera MJJ. Enfermedad trofoblástica gestacional. Prevalencia y características epidemiológicas en el Centro Médico IMSS Torreón. Ginecol Obstet Mex 1991;59:134-7.

17. Harriet O, Smith MD. Gestational trophoblastic disease: epidemiology and trends. Clin Obstet Gynecol 2003;46:541-56.

18. Valentín MCR, Álvarez PV. Comportamiento de la neoplasia trofoblástica gestacional durante 10 años. Rev Cubana Obstet Ginecol 2002;28:158-60.

19. Panduro BJG, Lagos TJ, González HAG, Amescua GG. Mola hidatiforme en el Nuevo Hospital Civil en Guadalajara. Ginecol Obstet Mex 1994;62:197-200.

20. Gorodner OZ, De Maidana R, Vadillo DJ, Czernik LC et al. Enfermedad trofoblástica gestacional en un servicio hospitalario de la ciudad de Corrientes. Soc Obstet Ginecol UNNE 2001;3:63-67.

21. Quiñónez CA, Martínez CM, Matienzo GC, Piña LN. Embarazo molar: estudio en el periodo 1994-1999 en el Hospital Provincial Ginecoobstétrico de Cienfuegos. Rev Cubana Obstet Ginecol 2001;27(3):221-5.

22. Jefferson L, Vicuña R, Rechkemmer A. Factores de riesgo en enfermedad trofoblástica gestacional: estudio caso-control. Perú Ginecol Obstet 1994;40:70-74.

23. Lira PJ, Tenorio GF, Gomezpedroso RJ, Novoa VA, Aranda FC, Ibargüengoitia OF. Enfermedad trofoblástica gestacional. Experiencia de seis años en el Instituto Nacional de Perinatología. Ginecol Obstet Mex 1995;63:478-82.

24. Pacheco J, Alegre J, Paniagua G. Características clínicas y anatomopatológicas en mola hidatiforme. Anales de la Facultad de Medicina, Universidad de San Marcos, Perú, 2002;63(4):275-80.

25. Aitken SS, Benavides MA, Smirnow SM. Neoplasia trofoblástica gestacional: Hospital Félix Bulnes Cerda, 1992-2002. Chil Obstet Ginecol 2004;69:353-6.

26. Romero GG, Baron VS, Avecilla HAA, Ponce PAL. Embarazo molar no sospechado en abortos del primer trimestre. Ginecol Obstet Mex 2003;71:55-59.

27. Cruz OH, López LJJ, Alcántara VA, Jastrow BL, Miranda HH. Coriocarcinoma gestacional avanzado. Estudio clínico patológico de 40 casos. Ginecol Obstet Mex 1995;63:384-7.

28. Belfort P, Braga A. Recurrent gestational trophoblastic disease. Rev Bras Obstet Ginecol 2003;25:61-66.